Guardant Health (GH) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Guardant Health (GH) reported a Q4 loss of $0.62 per share, which was larger than the Zacks Consensus Estimate of a $0.50 loss. However, the company showed improvement compared to a $1.58 loss per share a year ago.
February 21, 2025 | 12:00 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Guardant Health reported a Q4 loss of $0.62 per share, missing the Zacks Consensus Estimate of a $0.50 loss. Despite this, the loss is an improvement from the previous year's $1.58 per share.
The reported loss per share was worse than expected, which is typically negative for stock prices. However, the improvement from the previous year's loss may mitigate some negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100